Multisystem Inflammatory Syndrome in Children (MIS-C): Clinical Trials

1 trial for Multisystem Inflammatory Syndrome in Children (MIS-C), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Multisystem Inflammatory Syndrome in Children (MIS-C): new trials by email Literature Review of Multisystem Inflammatory Syndrome in Children (MIS-C) trials Research Report on Multisystem Inflammatory Syndrome in Children (MIS-C)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Contrast Enhanced Ultrasound in COVID-19
Sulfur hexafluoride lipid-type A microspheres - Covid19, Multisystem Inflammatory Syndrome in Children (MIS-C)
Phase 3CompletedChildren's Hospital of Philadelphia42020-12-182024-07-30

Narrower conditions

COVID-19 (1)  ·  pediatric multisystem inflammatory disease, COVID-19 related (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Sponsors

Children's Hospital of Philadelphia (1)

Countries

United States (1)

Results publications

PMID 35081803, PMID 36030353